SCHEMBL10375464

SCHEMBL10375464

NC(CO)c1nc2c(C(F)(F)F)cccc2c(O)c1C(=O)Nc1nccs1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
HSPA5 P11021 5/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SCN9A Q15858 1/20 0.40
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
DDAH1 O94760 1/20 0.39
HSPA2 P54652 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10737592 0.93 HSPA5 (0.44) HTTLMNATSHRHSPA5MEN1
SCHEMBL9601722 0.90 SCN9A (0.45) HTTLMNATSHRMEN1KMT2A
SCHEMBL10740580 0.90 HTT (0.42) HTTLMNATSHRHSPA5MEN1
SCHEMBL10744027 0.90 HTT (0.42) HTTLMNATSHRHSPA5MEN1
SCHEMBL10741576 0.90 HSPA5 (0.47) HTTLMNATSHRHSPA5MEN1
SCHEMBL10739618 0.88 HSPA5 (0.43) HTTLMNATSHRHSPA5MEN1
SCHEMBL10942295 0.88 HTT (0.44) HTTLMNATSHRHSPA5MEN1
SCHEMBL11620300 0.88 HTT (0.44) HTTLMNATSHRHSPA5MEN1
SCHEMBL10659235 0.87 HTT (0.43) HTTLMNATSHRHSPA5MEN1
SCHEMBL10941363 0.87 LMNA (0.43) HTTLMNATSHRHSPA5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0169755-B1 4-HYDROXY-3-QUINOLINE-CARBOXYLIC-ACID DERIVATIVES SUBSTITUTED AT 2 BY A NITROGEN-CONTAINING GROUP, THEIR PREPARATION, THEIR USE AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES ROUSSEL-UCLAF (FR) 1990-05-09 EP disclosed